These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8615656)

  • 1. Differential expression of cerbB3 in naevi and malignant melanomas.
    Korabiowska M; Mirecka J; Brinck U; Hoefer K; Marx D; Schauer A
    Anticancer Res; 1996; 16(1):471-4. PubMed ID: 8615656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions.
    Korabiowska M; Brinck U; Mirecka J; Kellner S; Marx D; Schauer A
    In Vivo; 1995; 9(5):433-8. PubMed ID: 8900920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
    Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
    Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.
    Korabiowska M; Brinck U; Ruschenburg I; Schlott T; Droese M; Stachura J
    Pol J Pathol; 1999; 50(1):17-21. PubMed ID: 10412270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
    Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Kellner S; Marx D; Schauer A
    Anticancer Res; 1995; 15(3):885-9. PubMed ID: 7645976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion molecule profile and malignancy of melanocytic lesions.
    Moretti S; Martini L; Berti E; Pinzi C; Giannotti B
    Melanoma Res; 1993 Aug; 3(4):235-9. PubMed ID: 8219755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
    Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
    Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nm23 in melanoma progression and its prognostic significance.
    Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
    Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
    Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
    Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
    Lyle S; Salhany KE; Elder DE
    Mod Pathol; 2000 Jan; 13(1):52-5. PubMed ID: 10658910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
    Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
    Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas.
    Korabiowska M; Betke H; Kellner S; Stachura J; Schauer A
    Anticancer Res; 1997; 17(5A):3697-700. PubMed ID: 9413226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
    Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
    Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
    Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
    Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.